PMID- 30209532 OWN - NLM STAT- MEDLINE DCOM- 20190501 LR - 20190501 IS - 1432-2072 (Electronic) IS - 0033-3158 (Linking) VI - 235 IP - 11 DP - 2018 Nov TI - Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats. PG - 3233-3241 LID - 10.1007/s00213-018-5026-1 [doi] AB - RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) preferentially increases synaptic serotonin (5HT). This response was attenuated following repeated exposure but there was recovery as a result of abstinence. Effects of abstinence on self-administration of many drugs have been documented but the impact on MDMA self-administration is unknown. OBJECTIVE: This study compared the effects of abstinence on MDMA and cocaine self-administration. METHODS: Six-hour daily MDMA or cocaine sessions were conducted until a total of 350 mg/kg had been self-administered. Following this, rats were randomly assigned to either a 0- or 14-day abstinence group. Self-administration testing then continued for an additional 7 days. RESULTS: The latency to self-administer 350 mg/kg was shorter for rats that self-administered cocaine. The temporal distribution of responding within each test session also differed; MDMA self-administration was high during the first hour of each session, and decreased during subsequent hours, whereas cocaine self-administration was evenly distributed throughout each hour of the session. Abstinence decreased MDMA but not cocaine self-administration. CONCLUSIONS: The selective reduction of MDMA self-administration following abstinence is consistent with the idea that MDMA-stimulated 5-HT release is inhibitory to MDMA self-administration. FAU - Highgate, Quenten AU - Highgate Q AD - School of Psychology, Victoria University of Wellington, Wellington, 6011, New Zealand. FAU - Schenk, Susan AU - Schenk S AUID- ORCID: 0000-0002-7786-8313 AD - School of Psychology, Victoria University of Wellington, Wellington, 6011, New Zealand. susan.schenk@vuw.ac.nz. LA - eng PT - Comparative Study PT - Journal Article DEP - 20180912 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Adrenergic Uptake Inhibitors) RN - 0 (Dopamine Uptake Inhibitors) RN - 333DO1RDJY (Serotonin) RN - I5Y540LHVR (Cocaine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adrenergic Uptake Inhibitors/administration & dosage MH - Animals MH - Behavior, Addictive/metabolism/*psychology MH - Cocaine/*administration & dosage MH - Dopamine Uptake Inhibitors/administration & dosage MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*administration & dosage MH - Rats MH - Rats, Sprague-Dawley MH - Self Administration MH - Serotonin/metabolism MH - Substance Withdrawal Syndrome/metabolism/*psychology OTO - NOTNLM OT - Abstinence OT - Cocaine OT - MDMA OT - Self-administration OT - Serotonin EDAT- 2018/09/14 06:00 MHDA- 2019/05/02 06:00 CRDT- 2018/09/14 06:00 PHST- 2018/05/13 00:00 [received] PHST- 2018/09/04 00:00 [accepted] PHST- 2018/09/14 06:00 [pubmed] PHST- 2019/05/02 06:00 [medline] PHST- 2018/09/14 06:00 [entrez] AID - 10.1007/s00213-018-5026-1 [pii] AID - 10.1007/s00213-018-5026-1 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2018 Nov;235(11):3233-3241. doi: 10.1007/s00213-018-5026-1. Epub 2018 Sep 12.